IndraLab

Statements

Tofacitinib citrate inhibits JAK1. 1 / 22

21 | 1

reach

"Tofacitinib citrate which inhibits JAK1/JAK3 is approved for treatment of adults with moderately to severely active rheumatoid arthritis who have had an inadequate response to, or who are intolerant o[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

34126373

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Tofacitinib citrate inhibits JAK1. 1 / 22

INDRA sources:

Databases

Reading